期刊文献+

C-肽化学发光免疫分析方法学研究 被引量:3

The methodological study of C-peptide chemiluminescent immunoassay
下载PDF
导出
摘要 目的:建立人血清C-肽化学发光免疫分析法。方法:采用两株高特异的抗C-肽单克隆抗体,以一株包被微孔板制成固相抗体,另一株标记碱性磷酸酶,以金刚烷衍生物为底物,双抗体夹心法测定人血清C-肽浓度。结果:以5μg/ml单克隆抗体包被微孔板,酶结合物以1:5000稀释,在C-肽浓度0.1~15ng/ml范围内线性良好,线性方程为y=0.9575x-0.0869,相关系数0.99;灵敏度为0.01ng/ml,批内、批间变异系数分别为5.8%、8.4%;平均回收率98.4%,范围91.5%~105.0%。结论:文中建立的人血清C-肽化学发光免疫分析法,首次建立小分子人血清C-肽双抗体夹心化学发光免疫法测定。线性好,灵敏度较常规高出一个数量级,准确度和精密性高,能够满足一般临床诊断和科研的应用。 Objective:To develop chemiluminescent immunoassay for serum C-peptide. Methods:Two specific anti-C-peptide monoclonal antibodies were used in this assay, one coated in microplate, and the other labeled with alkaline phosphatase, adamantine derivative as substrate, determine the serum C-peptide with sandwich principle. Results: A monoclonal antibody was coated at 5 μg/ ml, enzyme-monoclonal antibody conjugate was diluted at 1:5 000. There was a good linearity at 0. 1-15 ng/ml of C-peptide concentration, linearity equation was y = 0. 957 5x -0. 086 9, correlation rate was 0. 99. The sensitivity was 0. 01 ng/ml, CV of intraassay and interassay were 5.8% ,8.4% respectively. The mean recovery rate was 98.4%, and range was 91.5%-105.0%. Conclusion:It is first time to report the small molecule polypeptide determined by two monoclonal antibodies sandwich CLIA. This assay had a good linearity, low detection limit and a excellent accuracy and precision. It can be used in clinical diagnosis and research.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2006年第9期848-851,共4页 Chinese Journal of Immunology
基金 国家科技部科技型中小企业创新基金资助(项目号04C26221100313)
关键词 化学发光免疫分析 C-肽 方法学 单克隆抗体 Chemiluminescent immunoassay (CLIA) C-peptide Methodology Monoclonal antibody
  • 相关文献

参考文献12

  • 1Clark P M.Assays for insulin,proinsulin(s) and C-peptide[J].Ann Clin Biochem,1999; 36:541-564.
  • 2Marques R G,Fontaine M J,Rogers J.C-peptide much more than a byproduct of insulin biosynthesis[J].Pancreas,2004; 29:231-238.
  • 3Wahren J,Ekberg K,Johansson J et al.Role of C-peptide in human physiology[J].Am J Physiol Endocrinol Metab,2000; 278:E759-E768.
  • 4Ekberg K,Brismar T,Johansson B L et al.Amelioration of sensory nerve dysfunction by C-peptide in patients with type 1 diabetes[J].Diabetes,2003; 52:536-541.
  • 5Cotter M A,Ekberg K,Wahren J et al.Effects of proinsulin C-peptide in experimental diabetic neuropathy[J].Diabetes,2003; 52:1812-1817.
  • 6Johansson B L,Wahren J,Pernow J.C-peptide increases forearm blood flow in patients with type 1 diabetes via a nitric oxide-dependent mechanism[J].Am J Physiol Endocrinol Metab,2003; 285:E864-E870.
  • 7Rigler A,Pramanik A,Jonasson P et al.Specific binding of proinsulin C-peptide to human cell membranes[J].PNAS,1999; 96(23):13318-13323.
  • 8Forst T,Dufayet D,Kunt T et al.Effects of proinsulin C-peptide on nitric oxide,microvascular blood flow and erythrocyte Na+,K+-ATPase activity in diabetes mellitus type Ⅰ[J].Clin Sci,2000; 98:283-290.
  • 9Torn C.C-peptide and autoimmune markers in diabetes[J].Clin Lab,2003;49:1-10.
  • 10American Diabetes Association.Report of the expert committee on the diagnosis and classification of diabetes mellitus[J].Diabetes Care,1997; 20:1183-1197.

同被引文献29

引证文献3

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部